Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Directors' Share Purchases

5th Jan 2009 12:09

RNS Number : 0917L
Biofutures International plc
05 January 2009
 



For Immediate Release

Biofutures International plc

('Biofutures' or the 'Company')

Notification of Dealings by Directors

5 January 2009

Biofutures International plc, the AIM listed investing company which seeks to establish, invest in, or acquire assets, partnerships, joint ventures, businesses or companies in Europe, Asia and the Middle East in the energy and utility sectors and their related infrastructures announces that it was notified of the following dealings by the directors of Biofutures ("Directors") on 5 January 2009 which were completed on the same day:-

Julie Pomeroy, Finance Director, purchased 400,000 ordinary shares of 1 penny each in the issued share capital of the Company ("Ordinary Shares"), representing approximately 0.26 per cent. of the issued share capital of the Company. The purchase was conducted at 1.25 pence per Ordinary Share. Following this purchase Julie Pomeroy is now beneficially interested in 600,000 Ordinary Shares which represents approximately 0.40 per cent. of the issued share capital of the Company.

David Long, Non-Executive Director, purchased 400,000 Ordinary Shares at 1.25 pence per Ordinary Share. Following this purchase David Long is now beneficially interested in 400,000 Ordinary Shares which represents approximately 0.26 per cent. of the issued share capital of the Company.

Patrick Howes, Non-Executive Director, purchased 240,000 Ordinary Shares at 1.25 pence per Ordinary Share. Following this purchase Patrick Howes is now beneficially interested in 240,000 Ordinary Shares which represents approximately 0.16 per cent. of the issued share capital of the Company.

For further information please contact:

Julie Pomeroy, Finance DirectorBiofutures International plc 0117 920 0092

Emily Morgan, Blomfield Corporate Finance Limited 01275 871 717

Paul Vann, Winningtons Financial PR  0117 920 0092

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSLELFBKFBBBBV

Related Shares:

Graphene Nanochem
FTSE 100 Latest
Value8,275.66
Change0.00